PAD3-IN-1 (compound 14b) is an inhibitor of protein arginine deiminase (PAD) with over 10-fold selectivity for PAD3 over PAD1, PAD2, and PAD4; it can be used to study PAD-related neurodegenerative diseases, particularly those involving PAD3, which is associated with neurodegenerative responses following spinal cord injury.